EU authorizes AstraZeneca/Oxford COVID-19 vaccine


  • World
  • Saturday, 30 Jan 2021

BRUSSELS, Jan. 29 (Xinhua) -- The European Commission granted conditional marketing authorization for the COVID-19 vaccine developed by British company AstraZeneca and Oxford University on Friday, although the bloc seems unlikely to get the amount of doses as agreed for the moment.

"Securing safe vaccines for Europeans is our utmost priority. With the AstraZeneca vaccine now authorized, 400 million additional doses will be available in Europe," said European Commission President Ursula von der Leyen.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Buy now, pay later: Latin America pressured by Chinese online shops
Amazon launches an online discount storefront to better compete with Shein and Temu
South Korea top court upholds conviction of 'comfort women' activist over embezzlement
Australia to make big tech liable for citizens’ online safety
New Zealand parliament debates controversial bill as protesters march on capital
Philippines Marcos' says will not block ICC if ex-president Duterte wants to be investigated
Cross-border challenges widen wealth gap between Europe and US, IMF study finds
Trump taps firebrand congressman Matt Gaetz for attorney general
Bob Lee’s accused killer says tech executive ‘went crazy on me’
Think twice before sharing photos of your kids online, experts say

Others Also Read